Emission-particle-induced ventilatory abnormalities in a rat model of pulmonary hypertension.
Preexistent cardiopulmonary disease in humans appears to enhance susceptibility to the adverse effects of ambient particulate matter. Previous studies in this laboratory have demonstrated enhanced inflammation and mortality after intratracheal instillation (IT) and inhalation (INH) of residual oil fly ash (ROFA) in a rat model of pulmonary hypertension induced by monocrotaline (MCT). The present study was conducted to examine the effects of ROFA in this model on ventilatory function in unanesthetized, unrestrained animals. Sixty-day-old male CD rats were injected with MCT (60 mg/kg) or vehicle (VEH) intraperitoneally 10 days before IT of ROFA (8.3 mg/kg) or saline (SAL) (control) or nose-only INH of ROFA [15 mg/m3 for 6 hr on 3 consecutive days or air (control)]. At 24 and 72 hr after exposure, rats were studied individually in a simultaneous gas uptake/whole-body plethysmograph. Lungs were removed at 72 hr for histology. Pulmonary test results showed that tidal volume (VT) decreased 24 hr after IT of ROFA in MCT-treated rats. Breathing frequency, minute volume (VE), and the ventilatory equivalent for oxygen increased in MCT- and VEH-treated rats 24 hr after IT or INH of ROFA and remained elevated 72 hr post-IT. O2 uptake (VO2) decreased after IT of ROFA in MCT-treated rats. Carbon monoxide uptake decreased 24 hr after IT of ROFA, returning to control values in VEH-treated rats but remaining low in MCT-treated rats 72 hr post-IT. ROFA exposure induced histologic changes and abnormalities in several ventilatory parameters, many of which were enhanced by MCT treatment.
Gardner
Sarah Y
SY
College of Veterinary Medicine, North Carolina State University, 4700 Hillsborough Street, Raleigh, NC 27606, USA. Sarah_Gardner@ncsu.edu
McGee
John K
JK
Kodavanti
Urmila P
UP
Ledbetter
Allen
A
Everitt
Jeffrey I
JI
Winsett
Darrell W
DW
Doerfler
Donald L
DL
Costa
Daniel L
DL
D000818:Animals; D002244:Carbon / Q000008:administration & dosage / Q000633:toxicity*; D060729:Coal Ash; D004195:Disease Models, Animal; D006976:Hypertension, Pulmonary / Q000150:complications*; D007249:Inflammation; D019570:Inhalation Exposure; D008168:Lung / Q000473:pathology* / Q000502:physiology; D008297:Male; D016686:Monocrotaline / Q000008:administration & dosage; D010316:Particle Size; D052638:Particulate Matter; D051381:Rats; D017207:Rats, Sprague-Dawley; D012129:Respiratory Function Tests / Q000662:veterinary
D060729:Coal Ash; D052638:Particulate Matter; D016686:Monocrotaline; D002244:Carbon